Systematic review addresses risks and benefits of medicinal cannabis in mental health

One of the systematic review The study, entitled “The Differential Effects of Medical Cannabis on Mental Health,” by researchers at Erasmus University Rotterdam in the Netherlands, addresses the role of medical cannabis in the management of mental health conditions, highlighting its potential benefits and adverse effects, as well as the underlying mechanisms that contribute to its different effects on each individual. Medical cannabis has emerged as a promising, yet complex, alternative for the treatment of multiple mental health disorders. With a growing number of patients and clinicians exploring its therapeutic potential, it is important to understand the distinct and complex effects of cannabinoids on mental health.

The use of cannabis for medicinal purposes has a long history, dating back thousands of years of therapeutic use of the plant. However, its modern application in the treatment of mental health problems is a relatively recent field. As research progresses, medicinal cannabis is being considered for the treatment of conditions such as anxiety, depression, post-traumatic stress disorder (PTSD) and even schizophrenia. The complexity of its profile is largely due to the presence of several cannabinoids in the plant, which interact in multiple ways with the human endocannabinoid system. This dynamic interaction offers both potential therapeutic benefits and risks that require in-depth knowledge for safe application in each treatment.

Understanding mental health disorders and treatment challenges

Mental health disorders are multifaceted in nature and often require a personalized treatment approach. While conventional treatments, such as psychotherapy and medication, are effective for many patients, they are not the best option for everyone. In some cases, side effects associated with conventional medications may prompt patients to seek alternative treatments. Medical cannabis has been gaining traction as a supplemental or alternative option, due to its potential to alleviate symptoms in cases where conventional treatments have proven ineffective.

However, the challenge lies in the variability of patient responses. While some individuals experience marked improvements in symptoms, others may experience negative effects that can even worsen their disease. These contrasting results underscore the importance of personalized medicine and the need for continued research to determine who might benefit most from cannabis-based therapies.

Cannabinoids: How They Work in the Brain

At the heart of the debate over medicinal cannabis is the role of cannabinoids, chemical compounds in the cannabis plant that include tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is known primarily for its psychotropic properties, while CBD is recognized for its potential therapeutic effects without such associated side effects. Both cannabinoids interact with receptors in the brain’s endocannabinoid system, a network responsible for regulating mood, memory, sleep and appetite.

The endocannabinoid system includes receptors called CB1 and CB2. The CB1 receptor, predominantly located in the brain, is responsible for mediating the psychoactive effects of THC. In contrast, the CB2 receptor is more involved in regulating the immune system and controlling inflammation. The balance between the activation of these receptors is crucial for obtaining the beneficial or adverse effects of medicinal cannabis on mental health.

Positive impacts of medicinal cannabis on mental health

Several studies have highlighted the potential benefits of medicinal cannabis in the management of mental health disorders. For many patients, cannabis-based treatments have shown promise in reducing symptoms of anxiety, depression and chronic stress. The main positive effects of medicinal cannabis can be summarized as follows:

• Anxiety reduction: Low doses of CBD can have anxiolytic effects, relieving symptoms of social anxiety and general stress without significant psychoactive effects. This makes CBD an alternative for those struggling with conventional anxiety medications;
• Depression Management: Some studies suggest that cannabinoids may have a positive effect on mood by modulating neurotransmitter systems. This modulation may result in a reduction in depressive symptoms, particularly in patients who have not responded adequately to traditional antidepressants;
• Improved sleep: Medical cannabis may have a positive impact on sleep quality in individuals suffering from insomnia. By influencing the sleep-wake cycle through cannabinoid receptors, patients may experience deeper, more restful sleep;
• PTSD symptom relief: In patients with PTSD, cannabis has been shown to be effective in relieving symptoms such as nightmares and anxiety, possibly contributing to an improvement in overall quality of life. Additionally, the calming effects of certain cannabinoids may help reduce hyperarousal, a common feature of PTSD.

Although these positive results raise optimism, they need to be considered within the broader context of individual variability and the likelihood of side effects.

Potential side effects and considerations

Despite the therapeutic potential of medicinal cannabis, it is not without its risks. Some patients may experience side effects that can worsen their mental health. The main concerns include:

• Psychosis and cognitive impairment: The association between high doses of THC and an increased risk of psychosis and cognitive deficits has been observed, especially in individuals with a predisposition to schizophrenia or psychiatric disorders. For these patients, the psychoactive properties of THC may trigger or intensify psychotic episodes;
• Exacerbation of anxiety: While low doses of CBD can reduce anxiety, high doses of THC can have the opposite effect, leading to increased anxiety or panic attacks. This biphasic response means that dosage is key to achieving therapeutic benefits without adverse effects;
• Dependence and tolerance: Regular cannabis use can lead to dependence in some individuals, making it difficult to maintain consistent therapeutic effects. Over time, tolerance may develop, requiring higher doses that may increase the risk of side effects;
• Interactions with other medicines: Medical cannabis may interact with other drug treatments, potentially altering their effectiveness or increasing side effects. This is particularly important for patients who are already taking complex medication regimens for mental health or other medical conditions.

Given the potential risks identified, healthcare providers should closely monitor patients and tailor treatment plans to individual needs, ensuring that the benefits of medicinal cannabis outweigh the potential risks.

Mechanisms underlying differential effects

To understand why medical cannabis affects individuals differently, it is necessary to explore the complex mechanisms of the endocannabinoid system. Several factors contribute to the different effects in different individuals:

• Genetic variability: Genetic differences in cannabinoid receptor expression and endocannabinoid production may influence how individuals respond to cannabis. Variations in genes associated with neurotransmitter regulation may determine the extent of therapeutic benefit or the risk of adverse effects;
• Cannabinoid dosage and composition: The ratio of THC to CBD plays a crucial role in regulating the overall impact of medicinal cannabis. Products with higher levels of CBD are generally associated with fewer psychoactive effects, while THC-dominant products may provide more effective symptom relief, albeit with potential cognitive impairment as a trade-off;
• Individual medical and health history: The patient’s general health status, including pre-existing medical conditions and concomitant medication, may influence the response to cannabis. Therefore, personalized treatment approaches that take these factors into account are essential to optimize results;
• Environmental and psychological factors: Stress levels, lifestyle, and even expectations about treatment can modulate the effects of medical cannabis. A supportive environment and clear communication between patient and healthcare provider can maximize therapeutic benefits and reduce risks.

These factors highlight the complexity inherent in the use of medicinal cannabis in clinical practice. In this sense, adapted approaches that consider individual variability are essential to achieve the best results.

Future directions and research opportunities

The field of medicinal cannabis in mental health is a growing area with significant potential. However, there is still a vast amount of knowledge to be explored. Future research directions will include:

• Clinical trials with standardized formulations: More rigorous clinical trials using standardized cannabis formulations are needed to determine optimal cannabinoid dosages and ratios for various mental health conditions. This standardization will help clinicians make more informed decisions;
• Longitudinal studies: Long-term studies examining the effects of chronic cannabis use on mental health will provide valuable insights into its safety and efficacy. Such research is critical to understanding the potential for long-term dependence, tolerance and cognitive impairment;
• Personalized medicine approaches: Advances in genetic testing and biomarker research may in the near future make personalized treatments with medicinal cannabis possible. Tailoring treatments to individual genetic profiles and medical history could maximize therapeutic benefits and minimize adverse effects;
• Studies of mechanisms of action: Continued research into the mechanisms of action of cannabinoids will contribute to a deeper understanding of the interaction of these compounds with the endocannabinoid system. Further knowledge in this area may lead to the development of new therapeutic agents that offer specific benefits for mental health disorders.

Conclusions of the systematic review

Medical cannabis represents a frontier in mental health treatment, offering both great potential and significant challenges. The diverse effects observed, ranging from alleviating symptoms of anxiety, depression and PTSD to reducing the risk of adverse outcomes such as psychosis and cognitive impairment, highlight the need for tailored approaches and continued research. A deeper understanding of the interaction of cannabinoids with the endocannabinoid system will enable researchers and clinicians to optimise the therapeutic benefits of medical cannabis, while mitigating its risks.

As the industry continues to evolve, the promise of medical cannabis for improving mental health outcomes remains strong. With more research and a deeper understanding of individual variability, medical cannabis could become a valuable component of personalized mental health care strategies, offering hope to those who have not found relief with traditional treatments.

This systematic review stresses the need to carefully assess the risks and benefits of using medicinal cannabis for mental health. Healthcare professionals must remain informed and vigilant, ensuring that treatments are tailored to individual needs and based on sound scientific evidence.

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

João Xabregas

More postsBiography

With a professional background in CAD technical drawing (2D and 3D), João Xabregas is an activist and advocate for all uses and applications of cannabis. He discovered and entered the world of cannabis during his youth, where he developed a special interest in the cultivation of the plant, which led him on a journey of self-learning through the world of cannabis that continues to this day. His adventures linked to cannabis cultivation began with the same goal as many others: to be able to guarantee the quality and eliminate any possible risks to his health of what he consumed, as well as to avoid any type of dependence on the illicit market. However, he quickly began to view the world of cannabis and everything related to it with a very different perspective. He admits the enormous passion he has for the most persecuted plant in the world and about which he is always willing to write and have a good conversation.

• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Systematic review and meta-analysis demonstrate the potential of CBD in reducing seizure frequency in Epilepsy
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Portugal: New cannabis seizure in Grândola exposes yet another illegal trafficking operation disguised as a medicinal facility
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  SOMAÍ and Universidade Lusófona publish peer-reviewed study to improve practices in the production of full-spectrum cannabis oils
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  RAW Founder Josh Kesselman Buys High Times Magazine for $3,5 Million